Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE - Authors' reply
Isabelle Mahé1, Céline Chapelle2, Silvy Laporte3
1Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Service de Médecine Interne, Colombes 92700, France; Université Paris Cité, Paris, France; INSERM UMR-S970, Paris Cardiovascular Research Center, Team Endotheliopathy and Hemostasis Disorders, Paris, France; INNOVTE-FCRIN Network, Saint-Etienne, France.
No abstract available in PubMed .
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction

